Charis Eng, MD, PhD, FACP
Prof. Charis Eng is the inaugural Chair of the Cleveland Clinic’s Genomic Medicine Institute, inaugural Director, Center for Personalized Genetic Healthcare and Medical Director of the PTEN multidisciplinary clinic and national Center of Excellence, an American Cancer Society Clinical Research Professor and the Sondra J. and Stephen R. Hardis Endowed Chair of Cancer Genomic Medicine at the Cleveland Clinic. In her leadership roles, she continues to implement evidence-based genetic- and genomics-enabled precision healthcare, improving care for patients at genetic risk of disease nationally and globally. Her expertise lies in the genomics of heritable cancers, chief of which are those of the breasts and thyroid, exemplified by her expertise in those with PTEN hamartoma tumour syndrome. She has delineated the cancer risks in those with germline PTEN mutations and amongst the first to show the link between germline PTEN mutations and autism. With >500 peer-reviewed articles, she is an elected member of the National Academy of Medicine and was conferred the American Cancer Society Medal of Honor, among numerous awards. Prof Eng has served as advisory to DHHS Secretary’s Committee on Genetics, Health & Society and is Editor-in-Chief of Human Molecular Genetics, a Senior Editor of Cancer Research and an Associate Editor of npj Genomic Medicine.